Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Expanding Complexity of p53

15.09.2005


Researchers at the University of Dundee have discovered new levels of complexity in the regulation of the tumour suppressor gene p53, findings which could have a significant impact on the identification of patients at risk of developing aggressive cancer and in determining more efficient drug treatments.



The research has been led by Professor Sir David Lane and Dr Jean-Christophe Bourdon of the Cancer Research UK Cell Transformation Group at the University of Dundee. Prof Lane famously discovered the p53 protein, and continues to lead cutting edge research in this field.

The new findings, which are to be published on the 15 September in the journal, "Genes and Development", show that the p53 gene, the most frequently inactivated gene in human cancer, does not produce only one unique p53 protein as previously thought, but at least six different p53 proteins (isoforms). They also established that expression of p53 isoforms is abnormal in breast tumours.


"The discovery of p53 isoforms is a major breakthrough in the understanding of cancer formation," said Dr Bourdon.

"The determination of p53 isoform expression in human cancers will help to identify patients at risk of developing aggressive cancer and to define their drug sensitivity in order to treat the patient with the most efficient drugs."

"The deregulation of p53 isoform expression in tumours provides an explanation on how tumours can develop while they express a non-mutated p53 gene. As p53 isoforms are abnormally expressed in tumour cells, p53 is not fully active and does not destroy every cell which leads to cancer formation."

The different isoforms of p53 contain sections of the normal p53 protein, each put together in a slightly different way. All six isoforms can be found in normal human cells, though their levels vary in different tissues. Some of these isoforms can interact with full-length p53 to affect its tumour suppressing activity, suggesting that interactions between the different protein isoforms may be key in regulating p53’s normal role.

p53 activity is lost in over half of human tumours, which emphasises the importance of the p53 protein in preventing tumour formation. However, one of the puzzles facing workers in the p53 field is the role of p53 in tumours where it remains apparently normal.

Dr Bourdon and Prof Lane have examined the levels of these newly discovered p53 isoforms in breast tumours and find that some isoforms are present at abnormal levels in tumours which have otherwise normal p53.

This suggests that, in these tumours, p53 activity is being lost by altered isoform expression, rather than by mutation of the p53 gene itself. This important new finding tells us that alterations in levels of specific isoforms may play an essential role in tumour formation by regulating p53 activity. This new model will help to explain how p53 function in individual tumours is linked to the sensitivity of that tumour to drug treatment and give us new tools in the treatment of breast and other cancers.

Roddy Isles | alfa
Further information:
http://www.dundee.ac.uk/pressreleases/prsept05/p53.html
http://www.dundee.ac.uk

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>